search icon

    Market Snapshot

    • S&P Futures

      4,132.25

    • Dow Futures

      32,794

    • Nasdaq Futures

      13,101.5

    blog search icon

    Ovid Therapeutics Inc.

    (NASDAQ:OVID)

    $2.20

    -

    -

    Ovid Therapeutics Inc. Chart

    OVID Stock Price Today

    Ovid Therapeutics Inc. (OVID) stock declined over - intraday to trade at $2.2 a share on NASDAQ. The stock opened with a gain of 1.38% at $2.18 and touched an intraday high of $2.22, falling -0.00% against the last close of $2.2. The stock went to a low of $2.17 during the session.

    Stock Snapshot

    $2.2

    Prev. Close

    154.9 Million

    Market Cap

    $2.17

    Day Low

    $2.18

    Open

    70.35 Million

    Number of Shares

    $2.22

    Day High

    -

    P/E ratio

    -0.99

    EPS (TTM)

    2.37

    Cash Flow per Share

    0.63

    Free Float in %

    2.90

    Book Value

    31,153

    Volume

    Ovid Therapeutics Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-08-08$2.18$2.22$2.17$2.230,650
    2022-08-05$2.17$2.21$2.17$2.235,700
    2022-08-04$2.2$2.22$2.16$2.226,600
    2022-08-03$2.2$2.285$2.155$2.22329,400
    2022-08-02$2.093$2.2$2.05$2.2221,500
    2022-08-01$2.01$2.11$1.99$2.0857,500
    2022-07-29$1.96$2.1$1.93$2.0568,600
    2022-07-28$2.06$2.07$1.97$1.9937,300
    2022-07-27$2.08$2.1$2.025$2.0736,500
    2022-07-26$2.03$2.07$2.01$2.0242,400

    Contact Details

    1460 Broadway
    Suite 15021
    New York, NY 10036
    United States

    Webiste:OVID

    646 661 7661

    Company Information

    Employees-

    Beta1.24

    Sales or Revenue1.45 Million

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, and Northwestern University, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.

    Frequently Asked Questions

    icon

    What is the current Ovid Therapeutics Inc. (OVID) stock price?

    Ovid Therapeutics Inc. (NASDAQ: OVID) stock price is $2.2 as of the last check on Monday, August 8. During the trading session, OVID stock reached the peak price of $2.22 while $2.17 was the lowest point it dropped to.

    icon

    OVID's industry and sector of operation?

    The NASDAQ listed OVID is part of Biotechnology industry that operates in the broader Health Care sector. Ovid Therapeutics Inc. , a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States.

    icon

    Who are the executives of OVID?

    Dr. Jeremy Max Levin Ba Zoology, Dphil, Mb Bchir
    Pres, CEO & Chairman
    Mr. Jeffrey A. Rona
    Principal Financial Officer, Principal Accounting Officer & Chief Bus. and Financial Officer
    Mr. Thomas Michael Perone J.D., M.B.A.
    Gen. Counsel, Chief Compliance Officer & Corp. Sec.
    Dr. Matthew J. During Ph.D., M.D., DSc, FACP, FRACP
    Founder & Member of Scientific Advisory Board

    icon

    What is the OVID stock price today?

    OVID stock traded closed the last session at $2.2, which is $0 or 0% lower than its previous close of $2.2. OVID's current trading price is 33.33% lower than its 52-week high of $4.2 where as its distance from 52-week low of 1.65% is -47.62%.

    icon

    How many employees does OVID have?

    Number of OVID employees currently stands at -. OVID operates from 1460 Broadway, Suite 15021, New York, NY 10036, United States.

    icon

    Link for OVID official website?

    Official Webiste of $OVID is: https://www.ovidrx.com

    icon

    How do I contact OVID?

    OVID could be contacted at OVID operates from 1460 Broadway, Suite 15021, New York, NY 10036, United States, or at phone #646 661 7661 and can also be accessed through its website.

    icon

    How many shares of OVID are traded daily?

    OVID stock volume for the day was 31,153 shares while in the previous session number of OVID shares traded was 30,650 . The average number of OVID shares traded daily for last 3 months was 180.85 Thousands.

    icon

    How much did OVID change today?

    The percentage change in OVID stock occurred in the recent session was 0% while the dollar amount for the price change in OVID stock was $0.

    icon

    What price range OVID stock been trading in?

    In the recent session, the day high for OVID stock was $2.22 while the low for OVID stock touched on the day was $2.17.

    icon

    What is the market cap of OVID currently?

    The market value of OVID currently stands at 154.9 Million with its latest stock price at $2.2 and 70.35 Million of its shares outstanding.